StudyFinder

Semaglutide vs. Placebo in Subjects with NASH and Compensated Liver Cirrhosis

Status: OPEN TO ACCRUAL

I'm interested

Age:

Healthy Volunteers:

Interventions:

drug: Semaglutide

Conditions:

Diseases of Digestive System (520-579)

Contact(s): Grubb, Emily - Emily.Grubb@vcuhealth.org

Principal Investigator: Sanyal, Arun, J

Phase: II

IRB Number: HM20016500

System ID: NCT03987451

Back